D-(+)-CHIRO-INOSITOL

$ 100.00 /1GK

Min. Order1KG
Purity99
Cas No643-12-9
Supply Ability100kg
Update time2023-07-19

Wuhan wingroup Pharmaceutical Co., Ltd

4YR

China

Chemical Properties

Product Name	D-(+)-CHIRO-INOSITOL
CAS No	643-12-9
EC-No	211-394-0
Min. Order	1KG
Purity	99
Supply Ability	100kg
Release date	2023/07/19

D-(+)-CHIRO-INOSITOL cas:643-12-9 Details

_ueditor_page_break_tag_

Product Name	D-(+)-CHIRO-INOSITOL
Synonyms	cyclohexanehexol D-Inositol (1R,2R,3S,4S,5S,6S)-1,2,3,4,5,6-Cyclohexanehexol 1,2,3,4,5,6-Cyclohexanehexol, (1α,2α,3β,4α,5β,6β)- (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexol (1R,2R,3S,4S,5S,6S)-Cyclohexan-1,2,3,4,5,6-hexol 1,2,4/3,5,6-hexahydroxycyclohexane 1D-chiro-Inositol (+)-1,2,4/3,5,6-Inositol cis-inositol EINECS 211-394-0 D-Chiro-inositol(DCI) D-CHIRO-INOSITOL(DISD) MFCD00272608 D-(+)-Inositol D-chiro-inositol
CAS NO	643-12-9
ENIENCS	211-394-0
Molecular Formula	C6H12O6
Molecular Weight	180.156
Melting point	230 °C
Boiling Point	291.3±40.0 °C at 760 mmHg
Flash Point	143.0±27.9 °C
Density	2.0±0.1 g/cm3
Assay	99%
Grade	Pharmaceutical Grade
Solubility	N/A
Appearance	Light yellow or grayish-white powder
Storage	Store in an airtight container in a cool, dry place. Storage must be kept away from oxidizing agents. Cold storage
Packaging and Shipping	Aluminum foil bag, cartons, plastic contain,drums or as required; By Express, by Air, by Sea according to the Amount.
Usage	D-chiro-inositol is a Inositol differential isomer found in some mammalian glycosylphosphatidylinositol protein anchors and inositol-phosphatidylinositol glycan with insulin-like bioactivity. D-chiro-inositol is used for the treatment of polycystic ovary syndrome (PCOS) and diabetes. D-chir-inositol can reduce hyperglycemia and improve insulin resistance.

About conpany

_ueditor_page_break_tag_

Wuhan wingroup Pharmaceutical Co.,Ltd., located in Wuhan, Hubei Province, is a company dedicated to R & D,production and sales of chemical reagents, pharmaceutical intermediates, plantextracts and chemical raw materials. The company has a long-term cooperationwith Wuhan Research Institute and other universities. It is a pharmaceuticalenterprise oriented by the global pharmaceutical market demand and integratingthe research and development,

industrialization and market operation ofinnovative drugs. At present, the company has submitted 10 domestic patents andone PCT patent (International Patent); And obtained the authorization of 7invention patents. The company has strong technical strength, advanced

equipment,strict quality management system and high-quality after-sales service.

Over the years, our products have been widely sold to many countries and regions that we have established stable relations of cooperation with the traders and end users all around and have become a solid bridge among the suppliers, traders and end users.

FAQ

_ueditor_page_break_tag_